Cencora, Inc. (COR) is a Medical - Distribution company in the Healthcare sector, currently trading at $319.90. It has a SharesGrow Score of 53/100, indicating a mixed investment profile with 2 out of 7 criteria passed.
SharesGrow calculates the intrinsic value of COR = $386.89 (+20.9% from the current price, the stock appears undervalued). Analyst consensus target is COR = $408 (+27.5% upside).
Valuation: COR trades at a trailing Price-to-Earnings (P/E) of 38.6 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 3.56.
Financials: revenue is $321.3B, +10.4%/yr average growth. Net income is $1.6B, growing at -2.6%/yr. Net profit margin is 0.5% (thin). Gross margin is 3.2% (-0.3 pp trend).
Balance sheet: total debt is $10.7B against $1.5B equity (Debt-to-Equity (D/E) ratio 7.13, leveraged). Current ratio is 0.9 (tight liquidity). Debt-to-assets is 14%. Total assets: $76.6B.
Analyst outlook: 33 / 46 analysts rate COR as buy (72%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 32/100 (Fail), Growth 48/100 (Partial), Past 100/100 (Pass), Health 33/100 (Fail), Moat 49/100 (Partial), Future 79/100 (Pass), Income 30/100 (Fail).
